%0 Journal Article
%T Chinese expert consensus on diagnosis and management of severe asthma
%A Changgui Wu
%A Changzheng Wang
%A Chinese Medical Association
%A Chuntao Liu
%A Dong Yang
%A Jiangtao Lin
%A Kaisheng Yin
%A Mao Huang
%A Nan Su
%A Ping Chen
%A Shaoxi Cai
%A Xin Zhou
%A Yongming Zhang
%A and China Asthma Alliance
%A on behalf of Asthma Workgroup of Chinese Thoracic Society
%J SCIE-indexed Journal
%D 2018
%R 10.21037/jtd.2018.11.135
%X Bronchial asthma (referred to as ˇ°asthmaˇ± hereinafter in this consensus document) is a chronic inflammatory airway disease with well-accepted heterogeneity and complex pathophysiological processes (1). Severe asthma is recognized as a poorly controlled condition that seriously affects quality of life, accounts for massive use of medical resources, and imposes huge socioeconomic burdens, representing a primary cause of asthma-related disability and death in the patients (2-5). In this regard, improving the diagnosis and treatment of severe asthma should be of paramount importance towards better outcomes in overall control and prognosis, as well as lower medical costs (5)
%U http://jtd.amegroups.com/article/view/25863/html